- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Three Third-Party Tests Show Superior Performance of Nano-Scale Technology
nCoat, Inc. (OTCBB: NCOA) ("nCoat" or the "Company") today responded to industry and investor questions concerning uses of nanotechnology products under development. nCoat released information on three development projects currently in testing that are exploring the efficacy and performance of nano-scale coating (surface treatment materials) developed at the company. The testing was done by potential customers at their facilities. Internally, nCoat projects are administered by nTech, Inc., and the coatings are applied by High Performance Coatings, Inc. (HPC), two wholly owned subsidiaries of nCoat.
Working with customers, nCoat and its subsidiaries are focused on developing engineered coating solutions to meet and exceed increasingly high performance materials specifications. Through nTech, nCoat develops nano-scale coatings products principally focused on the following key aspects:
1. Continued improvements to proprietary binding and dispersion formulas;
2. Continued research and testing of the solids in coatings for new,
enhanced or new alternate functionality when applied to multiple
3. Improvement of materials and processes to further exploit binding
interactions between coatings source materials and between the coating
and the substrate;
4. Testing new uses for the high density, low porosity nano formulations;
5. Development and testing of new methods to create uniform sized nano
For the past several months, nTech has been working with an aerospace company with the objective to reduce the weight of exhaust system components that would thereby enable the weight reduction to be used for increased payload and fuel capacity.
The design solution called for ceramic matrix composites exposed to high temperature degradation risks while operating with sufficient tensile strength to maintain operational requirements. The use of nanotechnology provided a new, previously unknown solution by introducing the nano-formulated coating as a binding agent within the ceramic matrix. The primary benefit is created as the nano-coating penetrates deeper and more evenly in binding the materials. An added benefit to the mix is the nano-coating simultaneously provides thermal barrier functionality to the composite deriving previously unachievable performance. A secondary benefit results as nano-scaled materials penetrate so deeply and evenly, the temperatures required to cure the ceramic matrix composite are reduced from 1,800-2,100 degrees Fahrenheit to 650 degrees, representing a significant savings in the overall cost to manufacture the composite material.
A second challenge from the aerospace sector has called on nTech for the protection of substrate structural material in extreme temperature conditions against the unacceptable risks of thermal oxidation. Testing was performed for NASA involving thermal barrier coatings designed to enable the fuselage of spacecraft to endure exposure to 4,200°F for a period during orbital re-entry. The resultant incorporation of a formulated nano-coating increased the duration of protection by 78 times previous testing -- from ten seconds to thirteen plus minutes.
A third nTech project focuses on preventing rotor blade abrasion. Various industry coatings were tested on the edge of blades at high speeds to confirm protection against abrasion from rainfall. A standard rotor blade rain erosion test set tip speed at 632 feet per second, drenched the blades in simulated rainfall at a rate of three inches per hour and defined failure as erosion of the coating until an unbroken line of bare metal was exposed at the blade edge. Within 10-15 minutes, the industry-standard micron particulate coatings tested reached the failure point. The same test utilizing nCoat's nano-formulated product did not fail through the entire duration of a 60-minute test. The tests demonstrated a performance increase for the nTech coating by a factor of up to six times over the competition.
"These three examples are spectacular singular achievements. Collectively they raise the performance of custom formulated specialty coatings to new previously unattainable levels," commented Paul S. Clayson, Chairman and CEO of nCoat. "As these products complete their individual development cycles and begin high volume production, the new commercial prospects in the aerospace industry are substantial. These products could displace current standard coatings in the industry."
About nCoat, Inc.
Formed in 2004, nCoat, Inc. is an emerging nanotechnology company focused on the development of new nano-formulated and traditional coatings that make it an international leader in the development and marketing of coatings applied to metal, ceramics, fabric, and other materials. The company specializes in nanotechnology research, commercialization, licensing, and distribution, and through its subsidiary companies develops and distributes commercially viable proprietary nanotechnology and traditional coatings products. At nCoat, we invite the world to "Innovate with us."
About nTech, Inc.
nTech, Inc. is a for-profit intellectual property research, development, engineering, distribution and licensing company. A wholly owned subsidiary of nCoat, nTech holds and manages all proprietary intellectual property for nCoat and its other subsidiaries. nTech provides engineered coatings solutions and consulting, developing nano-formulated and micron-formulated high performance coatings that provide superior performance for numerous industries including automotive, aerospace, medical, weapons, and diesel engines sectors. nTech also develops processes, equipment and strategies for high volume production, plant and engineering specifications, quality control, safety training, and logistical supervision.
About HPC, Inc.
HPC has been an integral part of the automotive industry since 1982. HPC develops, manufactures, and applies coating (surface treatment) solutions for thermal management, anti-corrosion, friction reduction, bond strength, and appearance. HPC is a particular market leader in internal and external engine parts coatings in automotive and diesel engines. At HPC, there IS a difference, and the difference is superior performance.
Except for statements of historical fact, the information presented herein may contain forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to acquire and develop specific projects, the ability to fund operations and changes in consumer and business consumption habits and other factors over which nCoat, Inc. has little or no control. Statements in this press release which include words such as "anticipates," "plans," "potential," and similar terms may include forward-looking statements. Factors which could cause the Company's results to differ from the forward-looking statements include a decline or slower-than-anticipated growth in revenue opportunities related to the diesel engine manufacturing industry, and a decline or slower-than-anticipated growth in the demand and use for nano-formulated commercial products and related revenue streams for the Company, as well as listed in the "Risk Factors" sections of the Company's publicly filed reports. The Company expressly disclaims any obligation or intention to update any forward looking statement.
ON BEHALF OF THE BOARD
Paul S. Clayson, Chief Executive Officer
For more information, please click here
Investor Relations Contact:
Bakerview Investor Relations Inc.
Copyright © Market WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Nanotechnology identifies brain tumor types through MRI 'virtual biopsy' in animal studies: If results are confirmed in humans, tumor cells could someday be diagnosed by MRI imaging and treated with tumor-specific IV injections; new NIH grant will fund future study May 27th, 2015